PTPN1 and cancer: Conversely, tunicamycin, an ER stressor that does not inhibitPTP1B, showed no increase in ecto-CRT exposure, consistent with previousreports that tunicamycin alone did not trigger ICD. Additionally, we knocked down PTP1B in triple negativebreast cancer MDA-MB-231 cells (Supplementary Figure 33).